LEBRIQ Trademark

Trademark Overview

On Thursday, September 10, 2015, a trademark application was filed for LEBRIQ with the United States Patent and Trademark Office. The USPTO has given the LEBRIQ trademark a serial number of 86752938. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 29, 2019. This trademark is owned by GENENTECH, INC.. The LEBRIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of respiratory, immunologic and dermatological diseases
lebriq

General Information

Serial Number86752938
Word MarkLEBRIQ
Filing DateThursday, September 10, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 29, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of respiratory, immunologic and dermatological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 15, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990

Trademark Events

Event DateEvent Description
Monday, April 29, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 29, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 27, 2018EXTENSION 5 GRANTED
Monday, August 20, 2018EXTENSION 5 FILED
Friday, August 24, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 20, 2018TEAS EXTENSION RECEIVED
Thursday, January 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2018EXTENSION 4 GRANTED
Tuesday, January 16, 2018EXTENSION 4 FILED
Tuesday, January 16, 2018TEAS EXTENSION RECEIVED
Saturday, September 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 28, 2017EXTENSION 3 GRANTED
Thursday, September 28, 2017EXTENSION 3 FILED
Thursday, September 28, 2017TEAS EXTENSION RECEIVED
Thursday, March 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 14, 2017EXTENSION 2 GRANTED
Tuesday, March 14, 2017EXTENSION 2 FILED
Tuesday, March 14, 2017TEAS EXTENSION RECEIVED
Saturday, October 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 29, 2016EXTENSION 1 GRANTED
Thursday, September 29, 2016EXTENSION 1 FILED
Thursday, September 29, 2016TEAS EXTENSION RECEIVED
Tuesday, March 29, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 2, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 2, 2015ASSIGNED TO EXAMINER
Tuesday, September 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 14, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

lebriq dermatological diseases immunologic respiratory preparations treatment pharmaceutical